Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ONESOURCE.NSthis companyOnesource Specialty Pharma Ltd.	₹1,618.00	-228.63×	2.89×	11.87×	60.09×	-475.2%	32.0%	1.8%	-5.2%	-1.3%	0.3%	-4.0%	0.26×	4.62×	0.21×	0.99×	0.0%	2	4.26	1	C-
BIOCON.NSBiocon Limited	₹368.50	127.98×	1.45×	2.92×	18.14×	12.2%	34.8%	8.9%	2.3%	1.1%	2.3%	-1.1%	0.45×	3.61×	1.51×	1.22×	0.2%	6	1.63	2	C+
BLUEJET.NSBlue Jet Healthcare Limited	₹543.55	22.9×	4.17×	5.99×	18.93×	-77.2%	43.7%	28.5%	26.2%	18.2%	14.2%	0.0%	0.03×	-0.36×	43.29×	4.21×	0.4%	3	—	2	C
CONCORDBIO.NSConcord Biotech Limited	₹596.80	41.1×	5.32×	10.16×	25.54×	-74.8%	41.9%	27.8%	24.7%	12.9%	10.7%	1.6%	0×	-0.03×	1,034.4×	7.39×	1.0%	3	30.82	3	B+
DCAL.NSDishman Carbogen Amcis Limited	₹167.10	20.9×	0.3×	0.69×	7.34×	-102.0%	25.2%	7.6%	3.3%	1.5%	1.9%	3.8%	0.46×	3.71×	1.28×	1.23×	0.0%	3	—	2	C
GLAND.NSGland Pharma Limited	₹3,302.40	27.2×	2.7×	4.35×	12.94×	-57.3%	30.0%	18.8%	16.0%	9.9%	7.6%	2.6%	0.03×	-1.6×	36.24×	4.68×	1.1%	5	—	2	C+
Peer median	—	27.2×	2.7×	4.35×	18.14×	-74.8%	34.8%	18.8%	16.0%	9.9%	7.6%	1.6%	0.03×	-0.03×	36.24×	4.21×	0.4%	3	16.23	2	—